603087 甘李药业
已收盘 11-04 15:00:00
资讯
新帖
简况
甘李药业（603087）10月30日主力资金净卖出154.19万元
证券之星 · 10-31
甘李药业（603087）10月30日主力资金净卖出154.19万元
从胰岛素龙头迈向内分泌代谢创新药企 ——甘李药业举办2026研发开放日，全景披露研发战略与创新管线
中金财经 · 10-30
从胰岛素龙头迈向内分泌代谢创新药企 ——甘李药业举办2026研发开放日，全景披露研发战略与创新管线
甘李药业推进三重战略转型，前三季度营收同比增长10.57%
中金财经 · 10-30
甘李药业推进三重战略转型，前三季度营收同比增长10.57%
国金证券：给予甘李药业买入评级
证券之星 · 10-28
国金证券：给予甘李药业买入评级
图解甘李药业三季报：第三季度单季净利润同比增长15.67%
证券之星 · 10-28
图解甘李药业三季报：第三季度单季净利润同比增长15.67%
10月27日甘李药业跌5.14%，创新药ETF银华基金重仓该股
证券之星 · 10-27
10月27日甘李药业跌5.14%，创新药ETF银华基金重仓该股
甘李药业（603087）10月23日主力资金净买入1015.68万元
证券之星 · 10-24
甘李药业（603087）10月23日主力资金净买入1015.68万元
10月23日甘李药业涨7.46%，平安行业先锋混合基金重仓该股
证券之星 · 10-23
10月23日甘李药业涨7.46%，平安行业先锋混合基金重仓该股
甘李药业涨7.46%，国金证券一个月前给出“买入”评级
证券之星 · 10-23
甘李药业涨7.46%，国金证券一个月前给出“买入”评级
股市必读：甘李药业新发布《关于甘精胰岛素注射液（卡式瓶）获得萨尔瓦多药品注册批件的公告》
证券之星 · 10-19
股市必读：甘李药业新发布《关于甘精胰岛素注射液（卡式瓶）获得萨尔瓦多药品注册批件的公告》
甘李药业（603087）10月15日主力资金净买入2009.67万元
证券之星 · 10-16
甘李药业（603087）10月15日主力资金净买入2009.67万元
甘李药业最新公告：甘精胰岛素注射液获萨尔瓦多药品注册批件
证券之星 · 10-15
甘李药业最新公告：甘精胰岛素注射液获萨尔瓦多药品注册批件
股市必读：甘李药业新发布《关于GLR1075注射液Ⅰ期临床试验完成首例受试者给药的公告》
证券之星 · 10-14
股市必读：甘李药业新发布《关于GLR1075注射液Ⅰ期临床试验完成首例受试者给药的公告》
甘李药业（603087）披露GLR1075注射液Ⅰ期临床试验完成首例受试者给药公告，10月12日股价下跌3.6%
证券之星 · 10-12
甘李药业（603087）披露GLR1075注射液Ⅰ期临床试验完成首例受试者给药公告，10月12日股价下跌3.6%
甘李药业(603087.SH)：甘精胰岛素注射液(预填充笔)获得萨尔瓦多药品注册批件
智通财经 · 10-12
甘李药业(603087.SH)：甘精胰岛素注射液(预填充笔)获得萨尔瓦多药品注册批件
股市必读：甘李药业新发布《关于门冬胰岛素注射液获得埃塞俄比亚药品注册批件的公告》
证券之星 · 10-12
股市必读：甘李药业新发布《关于门冬胰岛素注射液获得埃塞俄比亚药品注册批件的公告》
甘李药业（603087）10月8日主力资金净卖出8034.21万元
证券之星 · 10-09
甘李药业（603087）10月8日主力资金净卖出8034.21万元
甘李药业：9月30日陈伟、李智、邢程、都凯、宋维强减持股份合计12.99万股
证券之星 · 10-08
甘李药业：9月30日陈伟、李智、邢程、都凯、宋维强减持股份合计12.99万股
甘李药业：9月29日陈伟、邹蓉、都凯、宋维强减持股份合计3.5万股
证券之星 · 09-30
甘李药业：9月29日陈伟、邹蓉、都凯、宋维强减持股份合计3.5万股
甘李药业（603087）9月28日主力资金净卖出529.80万元
证券之星 · 09-29
甘李药业（603087）9月28日主力资金净卖出529.80万元
加载更多
公司概况
公司名称：
甘李药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-06-29
主营业务：
甘李药业股份有限公司的主营业务是胰岛素类似物原料药及注射剂研发、生产和销售。公司的主要产品是甘精胰岛素注射液、赖脯胰岛素注射液、精蛋白锌重组赖脯胰岛素混合注射液、门冬胰岛素注射液、门冬胰岛素30注射液、精蛋白人胰岛素混合注射液。
发行价格：
63.32
{"stockData":{"symbol":"603087","market":"SH","secType":"STK","nameCN":"甘李药业","latestPrice":71.98,"timestamp":1793775600000,"preClose":69.15,"halted":0,"volume":8864480,"delay":0,"changeRate":0.0409,"floatShares":561000000,"shares":597000000,"eps":1.9807,"marketStatus":"已收盘","change":2.83,"latestTime":"11-04 15:00:00","open":69.02,"high":72.35,"low":68.92,"amount":629000000,"amplitude":0.0496,"askPrice":71.99,"askSize":6,"bidPrice":71.98,"bidSize":34,"shortable":0,"etf":0,"ttmEps":1.9807,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793842200000},"marketStatusCode":5,"adr":0,"adjPreClose":69.15,"symbolType":"stock","openAndCloseTimeList":[[1793755800000,1793763000000],[1793768400000,1793775600000]],"highLimit":76.07,"lowLimit":62.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":597432169,"isCdr":false,"pbRate":3.59,"roa":"--","peRate":36.340688,"roe":"7.25%","epsLYR":1.93,"committee":-0.238866,"marketValue":43003000000,"turnoverRate":0.0158,"status":0,"floatMarketCap":40411000000},"requestUrl":"/m/hq/s/603087","defaultTab":"news","newsList":[{"id":"2679226263","title":"甘李药业（603087）10月30日主力资金净卖出154.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679226263?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:17","pubTimestamp":1793405830,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，甘李药业报收于68.3元，上涨1.85%，换手率1.57%，成交量8.81万手，成交额6.04亿元。近5日资金流向一览见下表：甘李药业融资融券信息显示，融资方面，当日融资买入5134.23万元，融资偿还8572.25万元，融资净偿还3438.02万元。甘李药业主营业务：胰岛素类似物原料药及注射剂研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679575022","title":"从胰岛素龙头迈向内分泌代谢创新药企 ——甘李药业举办2026研发开放日，全景披露研发战略与创新管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2679575022","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679575022?lang=zh_cn&edition=full","pubTime":"2026-10-30 10:55","pubTimestamp":1793328917,"startTime":"0","endTime":"0","summary":"10月28日，甘李药业首届研发开放日在北京总部成功举办。此次活动以“与极致同行 为科学而生”为主题，围绕公司战略、创新管线、国际化布局与技术平台，首次对外全面拆解甘李药业研发战略、全景披露代谢产品管线矩阵，并针对中国创新药的发展生态、现状趋势等展开交流。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/30/20261030529099.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/30/20261030529099.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261030/32411704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","LNGR","603087","BK1574","MEDX","IBBQ","159992","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679257669","title":"甘李药业推进三重战略转型，前三季度营收同比增长10.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679257669","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679257669?lang=zh_cn&edition=full","pubTime":"2026-10-30 10:55","pubTimestamp":1793328917,"startTime":"0","endTime":"0","summary":" 同日晚间，甘李药业的三季报也出炉。报告显示，2026年1-9月，甘李药业实现营业收入33.69亿元，同比增长10.57%；归母净利润8.58亿元，同比增长4.86%。 从收入构成来看，2026年前三季度，甘李药业国内收入27.97亿元，同比增长3.96%，主要系胰岛素制剂产品销量增加；国际收入5.72亿元，同比增长60.38%，国际销售收入和国际特许权服务收入均大幅增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261030/32411703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678807844","title":"国金证券：给予甘李药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678807844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678807844?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:50","pubTimestamp":1793148631,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,马居东近期对甘李药业进行研究并发布了研究报告《业绩稳健增长，研发出海持续突破》，给予甘李药业买入评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为88.4。本文数据来源于国金证券股份有限公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678072001","title":"图解甘李药业三季报：第三季度单季净利润同比增长15.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678072001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678072001?lang=zh_cn&edition=full","pubTime":"2026-10-28 02:46","pubTimestamp":1793126775,"startTime":"0","endTime":"0","summary":"证券之星消息，甘李药业2026年三季报显示，前三季度公司主营收入33.69亿元，同比上升10.57%；归母净利润8.58亿元，同比上升4.86%；扣非净利润8.17亿元，同比上升17.96%；其中2026年第三季度，公司单季度主营收入11.46亿元，同比上升16.91%；单季度归母净利润2.48亿元，同比上升15.67%；单季度扣非净利润2.37亿元，同比上升15.67%；负债率12.44%，投资收益3277.89万元，财务费用-2081.07万元，毛利率74.87%。财报数据概要请见下图:本文数据来源于甘李药业2026年三季报，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800002996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678212811","title":"10月27日甘李药业跌5.14%，创新药ETF银华基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678212811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678212811?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:40","pubTimestamp":1793090446,"startTime":"0","endTime":"0","summary":"证券之星消息，10月27日甘李药业跌5.14%，收盘报68.31元，换手率1.59%，成交量8.91万手，成交额6.22亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共71家，其中持有数量最多的公募基金为银华基金的创新药ETF银华。创新药ETF银华目前规模为164.09亿元，最新净值0.814，较上一交易日上涨0.27%，近一年下跌10.18%。创新药ETF银华的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700030963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159316","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677903630","title":"甘李药业（603087）10月23日主力资金净买入1015.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677903630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677903630?lang=zh_cn&edition=full","pubTime":"2026-10-24 08:14","pubTimestamp":1792800864,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，甘李药业报收于72.0元，上涨7.46%，换手率2.09%，成交量11.75万手，成交额8.17亿元。近5日资金流向一览见下表：甘李药业融资融券信息显示，融资方面，当日融资买入7087.18万元，融资偿还7877.47万元，融资净偿还790.29万元。甘李药业主营业务：胰岛素类似物原料药及注射剂研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400006778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677944377","title":"10月23日甘李药业涨7.46%，平安行业先锋混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677944377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677944377?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:36","pubTimestamp":1792744586,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日甘李药业涨7.46%，收盘报72.0元，换手率2.09%，成交量11.75万手，成交额8.17亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为平安基金的平安行业先锋混合。平安行业先锋混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677294437","title":"甘李药业涨7.46%，国金证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2677294437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677294437?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:36","pubTimestamp":1792744576,"startTime":"0","endTime":"0","summary":"今日甘李药业涨7.46%，收盘报72.0元。2026年8月26日，国金证券研究员甘坛焕,马居东发布了对甘李药业的研报《二季度环比高增，出海及研发持续突破》，该研报对甘李药业给出“买入”评级。维持“买入”评级证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为77.02%。甘李药业个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578207","title":"股市必读：甘李药业新发布《关于甘精胰岛素注射液（卡式瓶）获得萨尔瓦多药品注册批件的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578207?lang=zh_cn&edition=full","pubTime":"2026-10-19 02:05","pubTimestamp":1792346712,"startTime":"0","endTime":"0","summary":"公司公告汇总：甘李药业甘精胰岛素注射液（卡式瓶）获萨尔瓦多药品注册批件，批件号BT004315102026，商品名VITAGLAR，适用于成人、青少年及2岁及以上儿童糖尿病治疗。该产品为长效胰岛素，每日注射一次，作用持续24小时。截至2026年6月30日，公司在该项目累计投入研发费用9.62亿元人民币。目前萨尔瓦多市场主要由赛诺菲供应同类产品。本次获批允许公司在萨尔瓦多销售该药品，但后续市场拓展存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675654559","title":"甘李药业（603087）10月15日主力资金净买入2009.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675654559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675654559?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:14","pubTimestamp":1792109688,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，甘李药业报收于69.5元，上涨1.03%，换手率1.5%，成交量8.4万手，成交额5.84亿元。近5日资金流向一览见下表：甘李药业融资融券信息显示，融资方面，当日融资买入4510.6万元，融资偿还6780.86万元，融资净偿还2270.26万元。甘李药业主营业务：胰岛素类似物原料药及注射剂研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600007119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675588883","title":"甘李药业最新公告：甘精胰岛素注射液获萨尔瓦多药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2675588883","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675588883?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:32","pubTimestamp":1792056778,"startTime":"0","endTime":"0","summary":"甘李药业(603087.SH)公告称，公司收到萨尔瓦多卫生监管总局核准签发的甘精胰岛素注射液(卡式瓶)注册批件，该药品用于成人、青少年及2岁及以上儿童的糖尿病治疗。甘精胰岛素为基础长效胰岛素，每天皮下注射一次，降糖作用时间持续24小时。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500028974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675366039","title":"股市必读：甘李药业新发布《关于GLR1075注射液Ⅰ期临床试验完成首例受试者给药的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675366039","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675366039?lang=zh_cn&edition=full","pubTime":"2026-10-14 00:58","pubTimestamp":1791910690,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，甘李药业报收于72.0元，下跌1.1%，换手率1.07%，成交量6.0万手，成交额4.31亿元。公司公告汇总关于GLR1075注射液Ⅰ期临床试验完成首例受试者给药的公告甘李药业自主研发的GLR1075注射液Ⅰ期临床试验完成首例受试者给药。该注射液为重组人白蛋白制剂，拟用于治疗肝硬化腹水低白蛋白血症。产品于2026年9月获国家药监局临床试验批准，累计研发投入8,191.61万元。截至2026年6月30日，该项目累计投入研发费用9.62亿元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674057028","title":"甘李药业（603087）披露GLR1075注射液Ⅰ期临床试验完成首例受试者给药公告，10月12日股价下跌3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674057028","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674057028?lang=zh_cn&edition=full","pubTime":"2026-10-12 22:53","pubTimestamp":1791816793,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，甘李药业报收于72.8元，较前一交易日下跌3.6%，最新总市值为434.93亿元。该股当日开盘75.51元，最高76.0元，最低72.74元，成交额达4.97亿元，换手率为1.2%。近日，甘李药业股份有限公司发布公告称，公司自主研发的GLR1075注射液Ⅰ期临床试验完成首例受试者给药。该注射液为重组人白蛋白制剂，拟用于治疗肝硬化腹水低白蛋白血症。产品于2026年9月获国家药监局临床试验批准，截至目前累计研发投入8,191.61万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200035784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876601","title":"甘李药业(603087.SH)：甘精胰岛素注射液(预填充笔)获得萨尔瓦多药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876601","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876601?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:50","pubTimestamp":1791798600,"startTime":"0","endTime":"0","summary":"智通财经APP讯，甘李药业(603087.SH)发布公告，公司收到萨尔瓦多卫生监管总局核准签发的甘精胰岛素注射液(预填充笔)注册批件(批件号：BT004008102026)。甘精胰岛素为基础长效胰岛素，每天皮下注射一次，降糖作用时间持续24小时。其具有作用时间长、血药浓度平稳无峰和平稳控糖的特点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674027843","title":"股市必读：甘李药业新发布《关于门冬胰岛素注射液获得埃塞俄比亚药品注册批件的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674027843","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674027843?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:39","pubTimestamp":1791740347,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，甘李药业报收于75.52元，上涨2.66%，换手率1.91%，成交量10.7万手，成交额7.93亿元。当日关注点交易信息汇总：10月9日主力资金净流出1620.53万元，占总成交额2.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674889466","title":"甘李药业（603087）10月8日主力资金净卖出8034.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674889466?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:35","pubTimestamp":1791506115,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，甘李药业报收于73.56元，下跌4.96%，换手率2.38%，成交量13.36万手，成交额9.97亿元。近5日资金流向一览见下表：甘李药业融资融券信息显示，融资方面，当日融资买入1.12亿元，融资偿还9901.48万元，融资净买入1285.94万元。甘李药业主营业务：胰岛素类似物原料药及注射剂研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074022","title":"甘李药业：9月30日陈伟、李智、邢程、都凯、宋维强减持股份合计12.99万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673074022?lang=zh_cn&edition=full","pubTime":"2026-10-08 20:01","pubTimestamp":1791460891,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月8日市场公开信息、上市公司公告及交易所披露数据整理，甘李药业最新董监高及相关人员股份变动情况：2026年9月30日公司董事,高级管理人员陈伟、高级管理人员李智、高级管理人员邢程、董事,高级管理人员都凯、董事,高级管理人员宋维强共减持公司股份12.99万股，占公司总股本为0.0217%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800030556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671019492","title":"甘李药业：9月29日陈伟、邹蓉、都凯、宋维强减持股份合计3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671019492","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671019492?lang=zh_cn&edition=full","pubTime":"2026-09-30 20:01","pubTimestamp":1790769691,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月30日市场公开信息、上市公司公告及交易所披露数据整理，甘李药业最新董监高及相关人员股份变动情况：2026年9月29日公司董事,高级管理人员陈伟、高级管理人员邹蓉、高级管理人员,董事都凯、董事,高级管理人员宋维强共减持公司股份3.5万股，占公司总股本为0.0058%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000034271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671266258","title":"甘李药业（603087）9月28日主力资金净卖出529.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266258","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266258?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:25","pubTimestamp":1790641516,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，甘李药业报收于73.96元，上涨0.71%，换手率1.69%，成交量9.49万手，成交额7.05亿元。近5日资金流向一览见下表：甘李药业融资融券信息显示，融资方面，当日融资买入5766.53万元，融资偿还7776.01万元，融资净偿还2009.48万元。甘李药业主营业务：胰岛素类似物原料药及注射剂研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793806399836,"stockEarnings":[{"period":"1week","weight":0.0123},{"period":"1month","weight":-0.1066},{"period":"3month","weight":-0.0178},{"period":"6month","weight":0.175},{"period":"1year","weight":0.055},{"period":"ytd","weight":0.0354}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0609},{"period":"3month","weight":-0.0697},{"period":"6month","weight":-0.1368},{"period":"1year","weight":-0.0926},{"period":"ytd","weight":-0.0909}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"甘李药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"67098人(较上一季度减少11.23%)","perCapita":"8367股","listingDate":"2020-06-29","address":"北京市通州区漷县镇南凤西一路8号","registeredCapital":"59743万元","survey":" 甘李药业股份有限公司的主营业务是胰岛素类似物原料药及注射剂研发、生产和销售。公司的主要产品是甘精胰岛素注射液、赖脯胰岛素注射液、精蛋白锌重组赖脯胰岛素混合注射液、门冬胰岛素注射液、门冬胰岛素30注射液、精蛋白人胰岛素混合注射液。","listedPrice":63.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"甘李药业,603087,甘李药业股票,甘李药业股票老虎,甘李药业股票老虎国际,甘李药业行情,甘李药业股票行情,甘李药业股价,甘李药业股市,甘李药业股票价格,甘李药业股票交易,甘李药业股票购买,甘李药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}